Los Gatos, CA – According to filings with the U.S. Securities and Exchange Commission, Supira Medical is raising $30,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Nitin Salunke played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Supira Medical
Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives. Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of the heart and enabling patients to undergo necessary interventional procedures. Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives.

To learn more about Supira Medical, visit http://supiramedical.com/

Contact:
Nitin Salunke, President and Chief Executive Officer
510-705-2569
https://www.linkedin.com/in/drnitinsalunke/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved